Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 248

    1.

    Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan.

    Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang SL.

    Diabetes Care. 2005 Nov;28(11):2756-61.PMID: 16249552 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

    Unwin N, Shaw J, Zimmet P, Alberti KG.

    Diabet Med. 2002 Sep;19(9):708-23. Review.PMID: 12207806 [PubMed - indexed for MEDLINE]Related articles

    3.

    High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.

    Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekker JM.

    Diabetes Care. 2007 Feb;30(2):332-6.PMID: 17259503 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

    DECODE Study Group, European Diabetes Epidemiology Group.

    Diabetes Care. 2003 Mar;26(3):688-96.PMID: 12610023 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of isolated post-challenge hyperglycemia on mortality in American Indians: the Strong Heart Study.

    Lu W, Resnick HE, Jain AK, Adams-Campbell LL, Jablonski KA, Gottlieb AM, Robbins DC, Howard BV.

    Ann Epidemiol. 2003 Mar;13(3):182-8.PMID: 12604162 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.

    Wei M, Gaskill SP, Haffner SM, Stern MP.

    Diabetes Care. 1998 Jul;21(7):1167-72.PMID: 9653614 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.

    Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen Maycock CA, Bair TL, Pearson RR, Carlquist JF; Intermountain Heart Collaborative Study Group.

    Am Heart J. 2003 Aug;146(2):351-8.PMID: 12891207 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.

    Nakagami T; DECODA Study Group.

    Diabetologia. 2004 Mar;47(3):385-94. Epub 2004 Feb 18.PMID: 14985967 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.

    Levitzky YS, Pencina MJ, D'Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS.

    J Am Coll Cardiol. 2008 Jan 22;51(3):264-70.PMID: 18206734 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

    DECODE Study Group, the European Diabetes Epidemiology Group..

    Arch Intern Med. 2001 Feb 12;161(3):397-405.PMID: 11176766 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease.

    Tai ES, Goh SY, Lee JJ, Wong MS, Heng D, Hughes K, Chew SK, Cutter J, Chew W, Gu K, Chia KS, Tan CE.

    Diabetes Care. 2004 Jul;27(7):1728-34.PMID: 15220254 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

    Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE.

    Circulation. 2007 Jul 10;116(2):151-7. Epub 2007 Jun 18.PMID: 17576864 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study.

    de Vegt F, Dekker JM, Ruhé HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

    Diabetologia. 1999 Aug;42(8):926-31.PMID: 10491751 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

    Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A.

    Diabetes Care. 1999 Jun;22(6):920-4.PMID: 10372242 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia.

    Qiao Q, Lindström J, Valle TT, Tuomilehto J.

    Diabet Med. 2003 Dec;20(12):1027-33.PMID: 14632705 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.

    Tsai SP, Wen CP, Chan HT, Chiang PH, Tsai MK, Cheng TY.

    Diabetes Res Clin Pract. 2008 Oct;82(1):148-56. Epub 2008 Aug 30.PMID: 18757109 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years.

    Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KM.

    Diabetes Res Clin Pract. 2003 Jun;60(3):177-82.PMID: 12757990 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of fasting glycemia on short-term prognosis after acute myocardial infarction.

    Vergès B, Zeller M, Dentan G, Beer JC, Laurent Y, Janin-Manificat L, Makki H, Wolf JE, Cottin Y.

    J Clin Endocrinol Metab. 2007 Jun;92(6):2136-40. Epub 2007 Apr 10.PMID: 17426093 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data